日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Evolution of Allogeneic Stem Cell Transplantation: Main Focus on AML

异基因造血干细胞移植的发展历程:主要关注急性髓系白血病

Inoue, Yoshitaka; Cioccio, Joseph; Mineishi, Shin; Minagawa, Kentaro

Cytotoxic lymphocytes induced by engineered human dendritic cells mediate potent anti-leukemia activity

经基因工程改造的人类树突状细胞诱导产生的细胞毒性淋巴细胞具有强大的抗白血病活性。

Zhao, Chenchen; Jia, Bei; Jiang, Yixing; Shike, Hiroko; Annageldiyev, Charyguly; Cioccio, Joseph; Minagawa, Kentaro; Mineishi, Shin; Ehmann, WChristopher; Schell, Todd D; Cheng, Hua; Zheng, Hong

Prior status of graft-versus-host disease affects donor lymphocyte infusion outcomes in patients with relapsed haematological malignancies after allogeneic stem cell transplantation.

既往移植物抗宿主病史会影响异基因造血干细胞移植后复发性血液恶性肿瘤患者的供体淋巴细胞输注结果

Velasco Claudia Mae, Inoue Yoshitaka, Cioccio Joseph, Rakszawski Kevin, Songdej Natthapol, Nickolich Myles, Zheng Hong, Naik Seema, Ehmann Christopher, Mierski Joseph, Silar Brooke, Vajdic Caitlin, Greiner Robert, Brown Valerie, Mineishi Shin, Shike Hiroko, Minagawa Kentaro

Safety and feasibility of intermediate-dose post-transplant cyclophosphamide for graft-versus-host disease prophylaxis

中等剂量移植后环磷酰胺预防移植物抗宿主病的安全性和可行性

Venugopal, Natasha; McGowan, Andrew; Inoue, Yoshitaka; Zheng, Hong; Cioccio, Joseph; Rakszawski, Kevin; Songdej, Natthapol; Nickolich, Myles; Naik, Seema; Ehmann, Christopher; Sivik, Jeffrey; Mierski, Joseph; Silar, Brooke; Vajdic, Caitlin; Shike, Hiroko; Mineishi, Shin; Minagawa, Kentaro

Recurrent disease after a matched sibling hematopoietic transplant in an aplastic anemia patient with a disease risk allele, HLA-B*40:02

患有再生障碍性贫血且携带疾病风险等位基因 HLA-B*40:02 的同胞造血干细胞移植后出现疾病复发

Khosla, Akshita; Inoue, Yoshitaka; Cioccio, Joseph; Rakszawski, Kevin; Songdej, Natthapol; Nickolich, Myles; Zheng, Hong; Naik, Seema; Ehmann, Christopher; Claxton, David; Rybka, Witold; Sivik, Jeffrey; Mierski, Joseph; Silar, Brooke; Vajdic, Caitlin; Hohl, Raymond; Shike, Hiroko; Mineishi, Shin; Minagawa, Kentaro